Eton Pharmaceuticals (ETON) Equity Ratio (2017 - 2025)

Eton Pharmaceuticals has disclosed Equity Ratio across 9 years of filings, most recently posting 0.28 for Q4 2025.

• Equity Ratio for Q4 2025 came in at 0.28, down 11.52% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.28 (down 11.52% YoY), and the FY2025 annual result was 0.28, down 11.52% from the prior year.
• Equity Ratio came in at 0.28 for Q4 2025 at Eton Pharmaceuticals, up from 0.22 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.69 in Q2 2021 to a low of 0.22 in Q3 2025.
• The 5-year median for Equity Ratio is 0.51 (2022), against an average of 0.48.
• Across the five-year window, Equity Ratio jumped 383.21% in 2021 and sank 50.37% in 2025, its largest moves.
• Eton Pharmaceuticals' Equity Ratio stood at 0.64 in 2021, then retreated by 18.6% to 0.52 in 2022, then decreased by 6.67% to 0.49 in 2023, then tumbled by 34.19% to 0.32 in 2024, then slipped by 11.52% to 0.28 in 2025.
• The last three Equity Ratio figures came in at 0.28 (Q4 2025), 0.22 (Q3 2025), and 0.24 (Q2 2025), per Business Quant data.